When to See a Doctor for Infertility — Age-Based Guidelines

Age Under 35 — The 12-Month Guideline

For women under 35 who have been having regular, unprotected intercourse without using contraception for 12 months without achieving pregnancy, the American Society for Reproductive Medicine (ASRM) and ACOG recommend seeking a formal fertility evaluation. About 85% of couples under 35 will conceive within 12 months of trying, and approximately 90% within 2 years. This 12-month guideline is not arbitrary — it accounts for the fact that even healthy couples with perfectly timed intercourse have only about a 20% to 25% chance of conceiving in any given cycle. The remaining 10% to 15% who have not conceived after 12 months represent the population in which an identifiable factor — whether ovulatory, tubal, uterine, or male — is present in roughly 40% of women and 40% to 50% of men. Waiting beyond 12 months does not improve the likelihood of natural conception and can delay effective treatment.

Age 35 to 39 — The 6-Month Guideline

For women aged 35 to 39, the ASRM and ACOG recommend seeking a fertility evaluation after only 6 months of unsuccessful trying. This shorter timeline reflects the accelerated decline in ovarian reserve and egg quality that begins around age 35. The per-cycle conception rate drops from approximately 20% to 25% in the late 20s to about 10% to 15% in the mid-30s. Beyond the reduced probability of conception per cycle, the risk of chromosomal abnormalities in offspring increases significantly — from about 1 in 1,250 at age 25 to about 1 in 100 at age 35 and roughly 1 in 30 by age 40. The risk of miscarriage also rises, reaching approximately 20% to 25% at age 35 and about 40% at age 40. Earlier evaluation allows for timely intervention and informed decision-making about fertility preservation options such as egg freezing.

Age 40 and Older — Immediate Evaluation

For women aged 40 and older who wish to conceive, ASRM recommends seeking a fertility evaluation immediately — even before attempting to conceive — because the per-cycle conception rate drops to approximately 5% and continues to decline rapidly toward menopause. By age 40, the ovarian reserve — measured by anti-Müllerian hormone (AMH) levels and antral follicle count (AFC) — has typically declined to a level where natural conception becomes very unlikely. The risk of chromosomal abnormalities reaches approximately 1 in 30, and miscarriage rates approach 50% to 60% by age 42. Fertility specialists may recommend donor egg IVF, which carries live birth rates of 50% to 60% per cycle, compared to approximately 10% to 15% per IVF cycle with own eggs at age 40. An early consultation allows for honest discussion of success rates, options, and timelines.

Red Flags That Warrant Earlier Evaluation

Certain conditions and history factors justify seeking a fertility evaluation well before the standard 12-month or 6-month timelines, regardless of age. These red flags include: menstrual cycles shorter than 21 days or longer than 35 days, which may indicate anovulation or luteal phase defects; a history of endometriosis, pelvic inflammatory disease (PID), or prior pelvic surgery, which can affect tubal patency and implantation; a prior diagnosis of sexually transmitted infections (particularly chlamydia or gonorrhea), which can cause tubal scarring; a history of chemotherapy or radiation, which can deplete ovarian reserve; known male factor issues such as prior vasectomy, testicular surgery, or low sperm count; and a history of two or more miscarriages, which may indicate a genetic or anatomical factor. Women with any of these factors should consult a reproductive endocrinologist as soon as they begin trying to conceive.

Fertility Diagnostic Tests

The standard fertility evaluation for both partners typically includes several tests conducted during the first few menstrual cycles. For the female partner, the hormone panel includes follicle-stimulating hormone (FSH) and estradiol on cycle day 3 to assess ovarian reserve, AMH (which can be measured at any time in the cycle), a thyroid stimulating hormone (TSH) test to rule out thyroid dysfunction, a prolactin level, and progesterone on cycle day 21 to confirm ovulation. A hysterosalpingogram (HSG) is an X-ray procedure that uses contrast dye to check whether the fallopian tubes are open and whether the uterine cavity is normal. For the male partner, a semen analysis — measuring sperm count, motility, and morphology — is the primary test and is non-invasive, inexpensive, and highly informative. Both partners should be evaluated simultaneously, as male factor issues account for 40% to 50% of all infertility cases.